D
Dotmatics
Scientific R&D software connecting data and decision-making
About Dotmatics
Dotmatics is a cloud-based R&D software company founded in 2005 in the United Kingdom and currently headquartered in Boston. It has since grown into a global provider of scientific informatics solutions with offices across Europe, Asia, and the U.S.
The company delivers an integrated software platform that supports data management and workflow automation for life sciences, chemistry, biology, and materials research. Its suite includes widely used applications such as GraphPad Prism, SnapGene, Geneious, and Luma, a low-code platform for multimodal drug discovery. Dotmatics enables over two million scientists across more than 10,000 organizations to capture, analyze, visualize, and share experimental data with greater efficiency and reproducibility.
Its platform automates critical research functions, including laboratory instrument data ingestion, electronic lab notebooks, assay analysis, and dashboard reporting. Dotmatics excels in harmonizing diverse scientific data into a unified environment, improving collaboration, reducing manual work, and accelerating the discovery process.
In April 2025, Dotmatics was acquired by Siemens for $5.1 billion and integrated into Siemens' Digital Industries Software division. This acquisition extended Siemens' AI-driven product lifecycle capabilities into the life sciences sector. Dotmatics reported an estimated $300 million in revenue for the 2025 fiscal year, with adjusted EBITDA margins exceeding 40 percent.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Boston, United States
- Employees
- 639
- Open positions
- 11
- Dealroom signal
- 73.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Data Analytics, Business Intelligence, Biotechnology, Core AI, Tech for Biotech and Pharma, Became $1B as Subsidiary, AI Applications, DT and LS
- Technology
- Artificial Intelligence, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 6 companies, latest Sep 2024
- Capital deployed
- $0
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jul 2025 | $5.1B | $5.1B | Siemens | ↗ |
| LATE VCOther financing | Dec 2021 | $95M | $380M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Dotmatics is 42K monthly website visits, down 8.7% over the last three months. Dotmatics's team grew 2.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
VirscidianRaleigh, United StatesWhat needs to be found…
→
BioGlyphBerkeley, United StatesNo more fidgeting around in PowerPoint
→
EasyPanelParis, France
→
M-StarEllicott City, United States
→
SoftGeneticsState College, United StatesResearchers and clinicians with software analysis tools for genetic analysis
$1Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Scottish Equity Partners
Series B and later1 investor entered at this stage
Other known investors2 additional known investors
Insightful Science
Siemens
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dotmatics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dotmatics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








